CRC Updates and Important Opportunities (10/24/2017)
Investigators and Study Personnel,
Please find attached the CRC presentation 'eSTAR and the CRC: What you need to know before Go-Live'.
Feel free to contact me if you have any questions. As always thank you for your support, and we look forward to serving you.
Lana Howard, BSN, RN, CCRP
VICTR-CRC Nurse Manager
Clinical Research Center Leadership Transition (9/27/2017)
Dear CRC staff, faculty, and other stakeholders,
It is with great appreciation that I write to let you know that after 30 years leading Vanderbilt's Clinical Research Center as Director, Dr. David Robertson will be stepping down from this role. During his tenure, the CRC became a thriving operation, with nationally recognized productivity in supporting translational science. The infrastructure and resources overseen by Dr. Robertson for several decades have provided support to investigators for the efficient conduct of investigations of compelling quality, most of which would never have been possible otherwise. In addition, Dr. Robertson's generosity in mentoring and guiding new trainees and faculty has been remarkable with numerous research careers stemming from his work in the CRC. Within VICTR, the CRC continues to facilitate a vibrant portfolio of advanced, mechanistic patient-oriented research and a full range of drug studies encompassing every stage of the process of drug development. It has become a flagship resource for VICTR and an envy of other institutions. We are deeply grateful to Dr. Robertson for his years of service and outstanding leadership in this role. A celebration is being planned (details to follow) for Dr. Robertson.
Dr. Kevin Niswender has agreed to serve as Acting Director of the CRC. Please welcome him to the CRC unit as of October 1, 2017.
Gordon R. Bernard, MD
Melinda Owen Bass Professor of Medicine
Executive Vice President for Research
Director, Vanderbilt Institute for Clinical and Translational Research